LP
NEOS

LMR Partners’s Neos Therapeutics, Inc NEOS Stock Holding History

LMR Partners’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,038
Closed -$22K – 612
2019
Q3 		$22K Hold
15,038
– – ﹤0.01% 396
2019
Q2 		$19K Buy
+15,038
New +$27.7K ﹤0.01% 403

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LMR Partners's NEOS Position: Q4 2019 in Review

LMR Partners sold out of Neos Therapeutics, Inc (NEOS) in Q4 2019, closing a stake of 15,038 shares — an estimated $22K sold.

LMR Partners first reported a position in NEOS in Q2 2019 and held it in 2 quarters. The position peaked at $22K in Q3 2019. 54 funds tracked by Wall St. Rank hold NEOS as of Q4 2019.

  • LMR Partners reported no remaining Neos Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • LMR Partners sold 15,038 Neos Therapeutics, Inc shares in Q4 2019, an estimated $22K.
  • LMR Partners first reported a position in Neos Therapeutics, Inc in Q2 2019 and held it in 2 quarters.
  • LMR Partners's Neos Therapeutics, Inc position peaked at $22K in Q3 2019.
  • 54 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2019.

Based on LMR Partners's 13F filing for Q4 2019, filed 14 Feb 2020.